Inventor · disambiguated record
Ngiap-Kie Lim
Also filed as: LIM NGIAP-KIE
18 granted patents·6 pending applications·26 citations·filing 2006–2024
90Inventor score
Files withGENENTECH INC15SCHERING CORP3THIRUVENGADAM TIRUVETTIPURAM K3HOFFMANN LA ROCHE1LEXICON PHARMACEUTICALS INC1
Top patents by PatentIndex Score
24 records- 0189US10385058B2Process for preparing BTK inhibitorsGENENTECH INC·Filed 2017·Granted Aug 20, 2019·3 cites·54 claims
- 0288US10882864B2Process for preparing BTK inhibitorsGENENTECH INC·Filed 2019·Granted Jan 5, 2021·3 cites·24 claims
- 0388US7605275B2Exo- and diastereo- selective syntheses of himbacine analogsSCHERING CORP·Filed 2006·Granted Oct 20, 2009·12 cites·11 claims
- 0487US10954234B2Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useGENENTECH INC·Filed 2019·Granted Mar 23, 2021·6 cites·81 claims
- 0584US11661424B2Process for preparing BTK inhibitorsGENENTECH INC·Filed 2020·Granted May 30, 2023·1 cites·11 claims
- 0680US2024409535A1Solid forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useGENENTECH INC·Filed 2024·Application pending·0 cites
- 0778US2024317738A1Solid forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useGENENTECH INC·Filed 2023·Application pending·0 cites
- 0878US2023250103A1Process for preparing btk inhibitorsGENENTECH INC·Filed 2023·Application pending·0 cites
- 0977US10968192B2Crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide and methods of their synthesisLEXICON PHARMACEUTICALS INC·Filed 2019·Granted Apr 6, 2021·1 cites·5 claims
- 1072US2025059155A1Process for synthesis of quinazoline compoundsGENENTECH INC·Filed 2024·Application pending·0 cites
- 1169US2025074893A1Synthesis of quinazoline compoundsGENENTECH INC·Filed 2024·Application pending·0 cites
- 1268US11780834B2Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useHOFFMANN LA ROCHE·Filed 2020·Granted Oct 10, 2023·0 cites·72 claims
- 1365US7989653B2Exo- and diastereo-selective syntheses of himbacine analogsSCHERING CORP·Filed 2009·Granted Aug 2, 2011·0 cites·21 claims
- 1462US12071422B2Process for synthesis of quinazoline compoundsGENENTECH INC·Filed 2023·Granted Aug 27, 2024·0 cites·48 claims
- 1559US11702452B2Process for making arylomycin ring analogsGENENTECH INC·Filed 2021·Granted Jul 18, 2023·0 cites·8 claims
- 1658US12172982B2Synthesis of quinazoline compoundsGENENTECH INC·Filed 2021·Granted Dec 24, 2024·0 cites·52 claims
- 1758US7772276B2Exo-selective synthesis of himbacine analogsSCHERING CORP·Filed 2006·Granted Aug 10, 2010·0 cites·10 claims
- 1854US11192924B2Process for making arylomycin ring analogsGENENTECH INC·Filed 2019·Granted Dec 7, 2021·0 cites·11 claims
- 1953US8618314B2Exo- and diastereo-selective synthesis of himbacine analogsWU GEORGE G·Filed 2012·Granted Dec 31, 2013·0 cites·4 claims
- 2052US8273790B2Exo-selective synthesis of himbacine analogsTHIRUVENGADAM TIRUVETTIPURAM K·Filed 2012·Granted Sep 25, 2012·0 cites·4 claims
- 2151US9975856B2Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acidGENENTECH INC·Filed 2016·Granted May 22, 2018·0 cites·13 claims
- 2251US2012302745A1Exo-selective synthesis of himbacine analogsTHIRUVENGADAM TIRUVETTIPURAM K·Filed 2012·Application pending·0 cites
- 2348US9969735B2Process for making tricyclic lactam compoundsGENENTECH INC·Filed 2017·Granted May 15, 2018·0 cites·15 claims
- 2448US8138180B2Exo-selective synthesis of himbacine analogsTHIRUVENGADAM TIRUVETTIPURAM K·Filed 2010·Granted Mar 20, 2012·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Ngiap-Kie Lim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →